Patient reported outcomes in randomized controlled cancer trials in advanced disease: a structured literature review.

about

Standards of reporting: the use of CONSORT PRO and CERT in individuals living with osteoporosis.Does the medical literature remain inadequately described despite having reporting guidelines for 21 years? - A systematic review of reviews: an update

P2860

Q52478641-0EF61C69-6A53-4112-90E4-8D9531CDA917 Q57491117-A2B55A8B-E46B-427E-9C8D-BE97E809D647

P2860

Patient reported outcomes in randomized controlled cancer trials in advanced disease: a structured literature review.

Item

http://www.wikidata.org/entity/Q38767126

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Patient reported outcomes in r ...... structured literature review.

@en

type

Item

label

Patient reported outcomes in r ...... structured literature review.

@en

prefLabel

Patient reported outcomes in r ...... structured literature review.

@en

P1476

Patient reported outcomes in r ...... structured literature review.

@en

P2093

C Weber

http://www.w3.org/2001/XMLSchema#string

D Mueller

http://www.w3.org/2001/XMLSchema#string

J Gaertner

http://www.w3.org/2001/XMLSchema#string

N Dargatz

http://www.w3.org/2001/XMLSchema#string

R Voltz

http://www.w3.org/2001/XMLSchema#string

S Stock

http://www.w3.org/2001/XMLSchema#string

V Weingärtner

http://www.w3.org/2001/XMLSchema#string

P2860

The Role of End-of-Life Issues in the Design and Reporting of Cancer Clinical Trials: A Structured Literature Review

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

What are surrogate outcome measures and why do they fail in clinical research?

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review

The selection and use of outcome measures in palliative and end-of-life care research: the MORECare International Consensus Workshop.

Evaluation of quality-of-life measures for use in palliative care: a systematic review.

Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers.

P304

821-829

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.2016.1164595

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26959869

http://www.w3.org/2001/XMLSchema#string

Patient reported outcomes in randomized controlled cancer trials in advanced disease: a structured literature review.

about

P2860

P2860

Patient reported outcomes in randomized controlled cancer trials in advanced disease: a structured literature review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698